Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of postpartum depression after cesarean section under epidural anesthesia
ChiCTR2200063913Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) and postoperative pain (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Postpartum depressive symptoms. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2200063913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063913.